Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

global access

- PMLiVE

The Power of Strong Partnerships

The Bedrock team reflects on what is critical to building strong partnerships.

Bedrock Healthcare Communications

- PMLiVE

Pfizer’s maternal RSV vaccine granted FDA approval to protect infants

The decision allows Abrysvo to be given to those who are 32 to 36 weeks into their pregnancy

- PMLiVE

Janssen’s Tecvayli approved by EC for reduced dosing frequency in multiple myeloma

Tecvayli was the first BCMA-targeting bispecific antibody to be approved in Europe

- PMLiVE

Boehringer sues US government over Medicare drug price negotiation programme

The IRA allows Medicare to negotiate lower prices for selected medicines

- PMLiVE

The rise of biologics: is the sector ready for future demand?

Looking at the evolving biological sector and the various capacity challenges that global biopharma companies will have to bridge

- PMLiVE

Medscape Education Launches 20th Older Driver Safety Educational Program

Education Supported by the National Highway Traffic Safety Administration

Medscape Education

regeneron headquarters

Regeneron’s Veopoz granted FDA approval for ultra-rare immune disease

Fewer than ten patients in the US have been diagnosed with CHAPLE disease

- PMLiVE

Merck shares positive late-stage results for Welireg in advanced kidney cancer

Renal cell carcinoma accounts for approximately 90% of kidney cancer diagnoses

- PMLiVE

Research shows new scientific technique could halve polio detection times

The new method could reduce costs and detection times for public health authorities

- PMLiVE

NICE recommends Amryt’s Filsuvez treatment for epidermolysis bullosa

Approximately 670 people in England are expected to benefit from the skin-wound-healing treatment

Tooth and nail

With Merck and BMS first out of the gates, here comes the assault on the Inflation Reduction Act

- PMLiVE

NIHR and EPSRC to invest £25m for research into long-term health conditions

An estimated 14 million people in England are living with MLTC

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links